KKR has acquired a majority stake in HealthCare Royalty Partners, pushing the investment firm further into the healthcare ...

As part of the transaction, HCRx Chairman and CEO Clarke Futch will continue to lead the HCRx team and will maintain an ongoing substantial minority interest in HCRx.

KKR & Co. Inc., a leading global investment firm, today announced that it has acquired a majority ownership stake in HealthCare Royalty Partners (HCRx), a leading biopharma royalty acquisition company ...

Investment firm KKR (KKR) announced on Wednesday the acquisition of a majority stake in the biopharma royalty acquisition company, HealthCare Royalty Partners.

KKR executives said strong momentum in their business gave them confidence on Thursday of beating earnings targets for 2026, ...

Investment giant KKR reported a 9% rise in adjusted net income for the second quarter on Thursday, bolstered by an increase ...

Detailed price information for KKR & Company LP (KKR-N) from The Globe and Mail including charting and trades.

KKR (NYSE:KKR) has experienced a notable price increase of 24% over the past month, coinciding with several significant developments. The company's planned relaunch of its waste management ...

KKR (KKR), searching for takeover targets amid volatile markets, is exploring a potential purchase of GPI SpA, an Italian healthcare technology firm, according to a media report on Wednesday.

STAMFORD, Conn.--(BUSINESS WIRE)--HealthCare Royalty Partners (“HCR” or the “Firm”), a global healthcare investment firm with $5.5 billion of cumulative capital commitments, today ...

KKR has secured a €2.6bn deal to buy Karo Healthcare, the maker of E45 moisturiser, defying a wider slump in dealmaking during the fallout from US President Donald Trump’s tariff policy.